A Goodwin Procter deal team advised investors in McKesson Corporation’s recently announced agreement to acquire MedVentive Inc. for an undisclosed figure.
Goodwin served as counsel to Ascension Health Ventures, HLM Venture Partners, Excel Medical Fund and other investors. Goodwin had previously served as counsel to these investors in connection with their last round of equity financing in MedVentive.
Formed in 2005 and based in Waltham, Mass., MedVentive is a leading provider of population and risk management tools for healthcare providers and payers nationwide, including large West Coast risk-based providers, some of the largest U.S. hospital systems, major academic medical centers and provider-based payers.
McKesson Corporation, currently ranked 14th on the Fortune 500, is a healthcare services and information technology company serving payers, hospitals, physician offices, pharmacies, pharmaceutical companies with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services.
“MedVentive is a leading provider of tools designed to assist healthcare organizations as they transition to become part of Accountable Care Organizations (ACOs),” said Michael Bison, a partner in Goodwin’s Technology Companies Group. “This acquisition was an important part of McKesson’s Better Health 2020 strategy, which is focused on identifying healthcare IT solutions to achieve better results for all stakeholders in the healthcare system. We were pleased to assist our long-standing clients in connection with this significant transaction.”
The deal team for this transaction included Bison, Daniel Lang, Carl Metzger, and Brian Mukherjee.